MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Renal & Urological Disorders

Unlock understanding in renal & urological disorders

The burden of renal and urological disease is increasing as U.S. and global populations age. Metabolomics is uniquely poised to drive the needed research and development to fuel greater understanding of these conditions and drive diagnostic and therapeutic opportunities.

  • Chronic kidney disease (CKD) and kidney failure (end-stage renal disease, ESRD)
  • Benign Prostatic Hyperplasia (BPH)
  • Urological Cancers
  • Chronic Pelvic Pain/Prostatitis/Interstitial Cystitis/ Bladder Pain Syndrome
  • Male Reproduction and Infertility
  • Nephrolithiasis
  • Sexual Dysfunction
  • Urinary Incontinence/Overactive Bladder (OAB)/Neurogenic Bladder (NGB)
  • Recurrent Urinary Tract Infections (UTIs)
TALK WITH AN EXPERT
See More Solutions
Identify disease mechanism

More understanding is needed surrounding the normal and abnormal function of renal and urological tissue at a molecular and cellular level. Untargeted metabolomics can be applied to cultured cells, tissues from model organisms, and patient biopsies to discover metabolic drivers of processes such as cell death and malignant transformation. These insights can be translated into actionable biomarkers through follow-on targeted assays.

Understand the relationship between urological disease and co-morbidities

Metabolic diseases are inextricably linked. Therefore, understanding the relationship between urological diseases and other co-morbidities like diabetes, metabolic syndrome, and obesity will help to inform disease prevention, diagnosis and treatment. Metabolon’s deep experience in metabolomics at the level of large patient cohorts plays a vital role in future advancements in the renal and urological field.

Study Design

Data Interpretation

Our Platform

Learn More

Related Resources

See All Resources
Microbiome SmartPanel™

Microbiome SmartPanel™

Metabolome modulation of the host adaptive immunity in human malaria

Metabolome modulation of the host adaptive immunity in human malaria

Collaboration Story: DNA Genotek and OMNImet®•GUT

Collaboration Story: DNA Genotek and OMNImet®•GUT

Load more

Enlighten your research,
accelerate your discovery.

Demo Our Data

Contact Us

Talk with an expert

Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.

    Get a Project Quote
    Send a Message
    Corporate Headquarters

    617 Davis Drive, Suite 100
    Morrisville, NC 27560

    Mailing Address:
    P.O. Box 110407
    Research Triangle Park, NC  27709

    +1 (919) 572-1711
    +1 (919) 572-1721
    International Headquarters

    Metabolon GmbH

    Zeppelinstraße 3
    85399 Hallbergmoos
    Germany

    +49 89 99017752

    Metabolomics

    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Insights & Discoveries

    Solutions

    • Products & Services
    • By Research & Development Phase
    • By Therapeutic Area
    • By Sector

    Insights

    • Our Latest Insights
    • Blog
    • News & Events
    • Publications

    Resources

    • Resource Library
    • Client Stories
    • COVID-19

    Company

    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
    Metabolon - Logo - Enlightening Life

    Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

    © 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

    in